2017
DOI: 10.1177/1010428317695947
|View full text |Cite
|
Sign up to set email alerts
|

MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1

Abstract: MicroRNA signature is altered in different disease states including cancer, and some microRNAs act as oncogenes or tumor suppressors. MiR-590-3p has been shown to be involved in human cancer progression. However, its role in hepatocellular carcinoma remains unknown. In this study, miR-590-3p level was measured, and clinicopathological features were determined in hepatocellular carcinoma tissues. The function of miR-590-3p was examined in vitro and in vivo. Real-time reverse transcription polymerase chain react… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
42
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 45 publications
(44 citation statements)
references
References 24 publications
(29 reference statements)
2
42
0
Order By: Relevance
“…31 In hepatocellular carcinoma cells, miR-590-3p suppresses cell growth in vitro and in vivo by targeting TEAD1. 33 In intrahepatic cholangiocarcinoma cells, miR-590-3p dramatically suppresses cell migration and invasion. 32 In breast cancer cells, miR-590-3p suppresses cell survival and triggers cell apoptosis via targeting sirtuin-1 and deacetylation of p53.…”
Section: Discussionmentioning
confidence: 99%
“…31 In hepatocellular carcinoma cells, miR-590-3p suppresses cell growth in vitro and in vivo by targeting TEAD1. 33 In intrahepatic cholangiocarcinoma cells, miR-590-3p dramatically suppresses cell migration and invasion. 32 In breast cancer cells, miR-590-3p suppresses cell survival and triggers cell apoptosis via targeting sirtuin-1 and deacetylation of p53.…”
Section: Discussionmentioning
confidence: 99%
“…Some of these miRNAs, including miR‐139, miR‐384, miR‐122, and miR‐188‐5p, have been shown to be downregulated in hepatocellular carcinoma and served as tumor suppressors. In contrast, some miRNAs are commonly upregulated and play oncogenic role in hepatocellular carcinoma, such as miR‐517a, miR‐151 and miR‐18a . However, in this research, we illustrated that miR‐490‐3p was low expressed in cell lines of Huh‐7, BEL‐7402 and HepG2.…”
Section: Discussionmentioning
confidence: 53%
“…Meanwhile, some research about miR‐490‐3p had been reported. For example, Ge and Gong showed that a tumor suppressor role of miR‐490‐3p in hepatocellular carcinoma via targeting transcriptional enhancer activator domain I ( TEAD I ) . Besides, Jiang et al illustrated that miR‐490‐3p upgrades proliferation and invasion in human HCCs via directly targeting TGF‐beta RII .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several important genes were found to be the direct target of miR‐590‐3p in different disease models. For instance, in cancers, miR‐590‐3p suppresses hepatocellular carcinoma growth by targeting TEAD1 (Ge & Gong, ), inhibits epithelial–mesenchymal transition in intrahepatic cholangiocarcinoma by targeting SIP1 (Zu et al, ), and represses migration, invasion, and epithelial–mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2 (Pang, Zheng, Zhao, Xiu, & Wang, ). In myocarditis, miR‐590‐3p was also identified as a novel miRNA that could target nuclear factor κ‐B in vivo (Zhao et al, ).…”
Section: Discussionmentioning
confidence: 99%